Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

 4,250.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 4,500.00
  • 52 Week Low: 2,635.00
  • Currency: UK Pounds
  • Shares Issued: 5.21m
  • Volume: 801
  • Market Cap: 221.33m

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (m) Pre-tax (m) EPS Dividend
31-Dec-19 Interim 5.27 4.26 69.28p 36.00p

Key Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-15 a4.33 a3.11 50.66p 17.3 0.4 +40% 32.60p 3.7%
30-Jun-16 a5.52 a4.22 69.18p 13.9 0.4 +37% 42.50p 4.4%
30-Jun-17 7.25 5.77 96.36p 19.8 0.5 +39% 51.00p 2.7%
30-Jun-18 7.98 6.87 110.21p 26.7 1.9 +14% 61.00p 2.1%
30-Jun-19 9.29 6.97 114.04p 32.8 8.2 +4% 73.00p 2.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-20 10.10 7.80 124.80p 34.1 3.6 +9% 88.00p 2.1%
30-Jun-21 11.10 8.60 136.80p 31.1 3.2 +10% 98.00p 2.3%

Copyright © 2020 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 32.80 13.91 22.11 1.69

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Bioventix Market Data

Currency UK Pounds
Share Price 4,250.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 4,500.00
52 Week Low 2,635.00
Volume 801
Shares Issued 5.21m
Market Cap 221.33m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
98.72% below the market average98.72% below the market average98.72% below the market average98.72% below the market average98.72% below the market average
92.86% below the sector average92.86% below the sector average92.86% below the sector average92.86% below the sector average92.86% below the sector average
Price Trend
87.04% above the market average87.04% above the market average87.04% above the market average87.04% above the market average87.04% above the market average
61.40% above the sector average61.40% above the sector average61.40% above the sector average61.40% above the sector average61.40% above the sector average
Income
77.08% below the market average77.08% below the market average77.08% below the market average77.08% below the market average77.08% below the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average
Growth
34.11% above the market average34.11% above the market average34.11% above the market average34.11% above the market average34.11% above the market average
8.57% above the sector average8.57% above the sector average8.57% above the sector average8.57% above the sector average8.57% above the sector average

Bioventix Dividends

  Latest Previous
  Interim Final
Ex-Div 09-Apr-20 31-Oct-19
Paid 28-Apr-20 15-Nov-19
Amount 36.00p 43.00p

Trades for 03-Jul-2020

Time Volume / Share Price
16:02 100 @ 4,250.00p
15:27 115 @ 4,200.00p
15:17 118 @ 4,230.00p
15:13 23 @ 4,232.00p
15:10 7 @ 4,232.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
Finance Director Treena Joan Turner
CFO Bruce Hiscock

Top of Page